T. Rowe Price Associates, Inc. 13D and 13G filings for Repligen Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:44 am Purchase |
2024-12-31 | 13G | Repligen Corporation RGEN |
T. Rowe Price Associates, Inc. | 7,136,086 12.700% |
743,841 (+11.64%) |
Filing |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Repligen Corporation RGEN |
T. Rowe Price Associates, Inc. | 6,392,245 11.400% |
273,275 (+4.47%) |
Filing |
| 2024-09-10 5:08 pm Purchase |
2024-08-31 | 13G | Repligen Corporation RGEN |
T. Rowe Price Associates, Inc. | 6,118,970 10.900% |
2,106,119 (+52.48%) |
Filing |
| 2024-02-14 10:02 am Sale |
2023-12-31 | 13G | Repligen Corporation RGEN |
T. Rowe Price Associates, Inc. | 4,012,851 7.200% |
-1,057,806 (-20.86%) |
Filing |
| 2023-02-14 12:37 pm Purchase |
2022-12-31 | 13G | Repligen Corporation RGEN |
T. Rowe Price Associates, Inc. | 5,070,657 9.100% |
2,028,002 (+66.65%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Repligen Corporation RGEN |
T. Rowe Price Associates, Inc. | 3,042,655 5.500% |
3,042,655 (New Position) |
Filing |